Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹18.76
Market cap: ₹44.48 Cr
Revenue (annual): ₹92.74 Cr
Net profit (annual): ₹4.96 Cr
P/E (TTM): 5.9×Sector 50.4×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

2 Sep 2026 18:38 IST BSE

Board Meeting Outcome

Kabra Drugs Board Meeting Outcome

Aanjaay Industries Limited announced the notice for its 37th Annual General Meeting and approved board agenda items, including the appointment of directors and auditors.

Read the filing ↗